Below you'll find a list of all posts that have been tagged as “life sciences”
Bringing a new therapy to market is one of the riskiest bets in pharma, nearly one in three launches falls short of expectations, while 60% underperform when multiple therapies compete in the same space. Competitive intelligence (CI) isn’t just a tactical tool, when integrated early and continuously across development, it guides trial design, shapes payer strategy, and equips commercial teams to pivot ahead of competitive threats.
Pharmaceutical launches carry far-reaching risk and opportunity, demanding strategic precision from early development through to market entry. Sedulo’s guide outlines how integrating competitive intelligence, market insights, and cross-functional alignment across four stages can help transform high stakes into sustainable success.
A top pharmaceutical company partnered with Sedulo Group to leverage pharma competitive intelligence and outmaneuver competitors in a high-stakes product launch.
In pharma, the competitive landscape evolves rapidly. This post outlines how strategic competitive intelligence helps life science teams anticipate market changes, monitor rivals, and inform smarter launch, pricing, and portfolio decisions.
A U.S.-based biopharmaceutical company faced competitive pressure from upcoming cardiovascular product launches and looming generic entry. Sedulo Group delivered targeted intelligence on competitor strategies, generic threats, and market vulnerabilities through a customized monitoring program. Armed with these insights, the client implemented counter-launch tactics, adjusted pricing and distribution, and protected its market position
To navigate a fast-changing chronic pain market, a leading pharma company partnered with Sedulo for targeted competitive intelligence, gaining timely insights that shaped strategy across brand, CI, and market access teams.
In unpredictable markets, resilience isn’t optional, it’s essential. This piece explores how economic and regulatory shocks test corporate strategies and why embedding agility and cross-functional coordination into CI frameworks empowers companies to weather turbulence and stay nimble.
Background A leading medical aesthetics company sought to prepare for a significant competitive disruption: the anticipated entry of a rival global manufacturer into the U.S. market. The client understood that this competitor’s entry would be accompanied by assertive marketing, differentiated product claims, and a well-funded commercial strategy, threatening to erode its market share and customer loyalty. To defend its position …
The Situation A global medical device manufacturer sought to deepen its competitive intelligence in the gastrointestinal (GI) space. As market dynamics evolved rapidly, driven by innovation in imaging systems, increased digitization, and shifting regulatory environments, the client aimed to benchmark its own R&D and sales strategies against key competitors in the GI medical device category. They needed to understand: How …
In a high-stakes, fast-moving pharma landscape, the best competitive intelligence partners do more than deliver data, they drive strategy. This post outlines eight essential traits that set leading CI firms apart, based on real-world buyer insights and evolving industry demands.
